LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Enliven Therapeutics (NASDAQ: ELVN)

Follow NASDAQ:ELVN Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
09/08/2025
Sell
$20.24
6,667
$135K
283,308
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2025
Sell
$2.48
3,250
$8K
108,306
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2025
Buy
$2.48
3,250
$8K
26,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
08/27/2025
Sell
$20.63
3,250
$67K
23,000
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
08/20/2025
Sell
$20.00
1,517
$30K
927,892
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
08/19/2025
Sell
$19.62
5,000
$98K
947,688
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
08/21/2025
Sell
$20.01
7,500
$150K
940,188
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
08/18/2025
Sell
$20.02
10,393
$208K
929,999
NASDAQ ELVN Enliven Therapeutics
Kintz Samuel / director, officer: PRESIDENT AND CEO
08/19/2025
Sell
$20.00
590
$12K
929,409
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
08/07/2025
Sell
$18.20
6,262
$114K
290,380
NASDAQ ELVN Enliven Therapeutics
Patel Anish / officer: CHIEF OPERATING OFFICER
08/07/2025
Sell
$18.93
405
$8K
289,975
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
07/28/2025
Sell
$2.48
3,250
$8K
111,556
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
07/28/2025
Buy
$2.48
3,250
$8K
26,250
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
07/28/2025
Sell
$20.45
3,185
$65K
23,065
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
07/28/2025
Sell
$21.30
65
$1K
23,000
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
07/21/2025
Sell
$22.26
11,924
$265K
953,264
NASDAQ ELVN Enliven Therapeutics
Lyssikatos Joseph P / officer: CHIEF SCIENTIFIC OFFICER
07/21/2025
Sell
$22.90
576
$13K
952,688

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous